Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Chan

Showing results (51-60 of 195) with videos related to

Pageof 20
Sort By:
Analytical Chemistry|September 18, 2015
Integrated glycoprotein immobilization method for glycopeptide and glycan analysis of cardiac hypertrophyShuang Yang, Sumita Mishra, Lijun Chen, et al.
Clinical Proteomics|May 16, 2012
The human proteome - a scientific opportunity for transforming diagnostics, therapeutics, and healthcareMarc Vidal, Daniel W Chan, Mark Gerstein, et al.
The Journal of Urology|April 13, 2004
Detection of prostate cancer using serum proteomics pattern in a histologically confirmed populationJinong Li, Nicole White, Zhen Zhang, et al.
Clinical Chemistry|May 25, 2002
Clinical evaluation of the Elecsys total prostate-specific antigen assay on the Elecsys 1010 and 2010 systemsAlexander Haese, Robert T Dworschack, Steven P Piccoli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancerEddy S Leman, Robert E Schoen, Ahmed Magheli, et al.
Urology|April 28, 2009
Investigation of human anti-mouse antibodies as potential cause of postprostatectomy PSA elevationStacy Loeb, Edward M Schaeffer, Daniel W Chan, et al.
The Journal of Urology|January 23, 2009
Predicting prostate cancer biochemical recurrence using a panel of serum proteomic biomarkersC Nicole Rosenzweig, Zhen Zhang, Xiaer Sun, et al.
Clinical Proteomics|May 12, 2017
An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumorsQing Kay Li, Punit Shah, Yuan Tian, et al.
Frontiers in Oncology|July 29, 2020
Proteomic Analysis of the Air-Way Fluid in Lung Cancer. Detection of Periostin in Bronchoalveolar Lavage (BAL)Yangying Zhou, Weiming Yang, Minghui Ao, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 6, 2002
Evaluation of the clinical performance of equimolar- and skewed-response total prostate-specific antigen assays versus complexed and free PSA assays and their ratios in discriminating between benign prostatic hyperplasia and prostate cancerFrank H Wians, Carol D Cheli, Jody A Balko, et al.
Pageof 20

Showing results (51-60 of 195) with videos related to

Sort By:
Pageof 20
Analytical Chemistry|September 18, 2015
Integrated glycoprotein immobilization method for glycopeptide and glycan analysis of cardiac hypertrophyShuang Yang, Sumita Mishra, Lijun Chen, et al.
Clinical Proteomics|May 16, 2012
The human proteome - a scientific opportunity for transforming diagnostics, therapeutics, and healthcareMarc Vidal, Daniel W Chan, Mark Gerstein, et al.
The Journal of Urology|April 13, 2004
Detection of prostate cancer using serum proteomics pattern in a histologically confirmed populationJinong Li, Nicole White, Zhen Zhang, et al.
Clinical Chemistry|May 25, 2002
Clinical evaluation of the Elecsys total prostate-specific antigen assay on the Elecsys 1010 and 2010 systemsAlexander Haese, Robert T Dworschack, Steven P Piccoli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancerEddy S Leman, Robert E Schoen, Ahmed Magheli, et al.
Urology|April 28, 2009
Investigation of human anti-mouse antibodies as potential cause of postprostatectomy PSA elevationStacy Loeb, Edward M Schaeffer, Daniel W Chan, et al.
The Journal of Urology|January 23, 2009
Predicting prostate cancer biochemical recurrence using a panel of serum proteomic biomarkersC Nicole Rosenzweig, Zhen Zhang, Xiaer Sun, et al.
Clinical Proteomics|May 12, 2017
An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumorsQing Kay Li, Punit Shah, Yuan Tian, et al.
Frontiers in Oncology|July 29, 2020
Proteomic Analysis of the Air-Way Fluid in Lung Cancer. Detection of Periostin in Bronchoalveolar Lavage (BAL)Yangying Zhou, Weiming Yang, Minghui Ao, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 6, 2002
Evaluation of the clinical performance of equimolar- and skewed-response total prostate-specific antigen assays versus complexed and free PSA assays and their ratios in discriminating between benign prostatic hyperplasia and prostate cancerFrank H Wians, Carol D Cheli, Jody A Balko, et al.
Pageof 20